In this cohort, participants with elevated Tyg levels had higher NT-pro BNP levels, lower LVEF, and a greater prevalence of comorbidities, including HF, stroke and CAD, all of which are correlated with adverse cardiovascular prognosis in patients with AF [1]. This evidence concerns the gene NPPB and atrial fibrillation.